![Pol Boudes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pol Boudes
Director/Board Member at
PROTALIX BIOTHERAPEUTICS, INC.
Net worth: 15 909 $ as of 31/05/2026
Profile
Pol F.
Boudes is currently an Independent Director at Protalix Biotherapeutics, Inc. since 2019, Chief Medical Officer at Rectify Pharmaceuticals LLC starting in 2024, and a member of the American Medical Association, European Association for the Study of the Liver, American Diabetes Association, The Royal Society of Medicine, and American Association for The Study of Liver Diseases.
Former roles include Chief Medical Officer at CymaBay Therapeutics, Inc. from 2014 to 2019, Chief Medical Officer at Amicus Therapeutics, Inc. from 2009 to 2013, Vice President-Global Clinical Development at Bayer HealthCare Pharmaceuticals, Inc. in 2009, Chief Medical Officer at Galectin Therapeutics, Inc. from 2020 to 2024, and Assistant Professor at Université Paris 1 Panthéon-Sorbonne.
Education includes a doctorate from Université d'Aix-Marseille.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/04/2026 | 7,540 ( 0.01% ) | 15 909 $ | 31/05/2026 |
Pol Boudes active positions
| Companies | Position | Start |
|---|---|---|
| PROTALIX BIOTHERAPEUTICS, INC. | Director/Board Member | 01/12/2019 |
American Association for The Study of Liver Diseases
 American Association for The Study of Liver Diseases Miscellaneous Commercial ServicesCommercial Services Operates as a healthcare organization to prevent and cure liver diseases | Corporate Officer/Principal | - |
American Medical Association
 American Medical Association Miscellaneous Commercial ServicesCommercial Services Protects the interests of physicians and supports the growth of medical science | Corporate Officer/Principal | - |
The Royal Society of Medicine
 The Royal Society of Medicine Miscellaneous Commercial ServicesCommercial Services Provide medical courses for continuing professional development | Corporate Officer/Principal | - |
American Diabetes Association
 American Diabetes Association Miscellaneous Commercial ServicesCommercial Services Provides diabetes related medical services | Corporate Officer/Principal | - |
European Association for the Study of the Liver
 European Association for the Study of the Liver Miscellaneous Commercial ServicesCommercial Services Liver research association | Corporate Officer/Principal | - |
Rectify Pharmaceuticals LLC
 Rectify Pharmaceuticals LLC BiotechnologyHealth Technology Operates as a biotechnology company that develops positive functional modulators | Chief Tech/Sci/R&D Officer | 01/08/2024 |
Former positions of Pol Boudes
| Companies | Position | End |
|---|---|---|
| GALECTIN THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 26/07/2024 |
| CYMABAY THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 30/09/2019 |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░ ░ ░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Pol Boudes
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
59
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Galectin Therapeutics, Inc.
 Galectin Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs to combat various diseases | Health Technology |
American Medical Association
American Medical Association Miscellaneous Commercial ServicesCommercial Services Protects the interests of physicians and supports the growth of medical science | Commercial Services |
CymaBay Therapeutics, Inc.
 CymaBay Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for people with life-threatening diseases | Health Technology |
Amicus Therapeutics, Inc.
 Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases | Health Technology |
European Association for the Study of the Liver
European Association for the Study of the Liver Miscellaneous Commercial ServicesCommercial Services Liver research association | Commercial Services |
American Diabetes Association
American Diabetes Association Miscellaneous Commercial ServicesCommercial Services Provides diabetes related medical services | Commercial Services |
Université Paris 1 Panthéon-Sorbonne
 Université Paris 1 Panthéon-Sorbonne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protalix Biotherapeutics, Inc.
 Protalix Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets recombinant therapeutic proteins | Health Technology |
The Royal Society of Medicine
The Royal Society of Medicine Miscellaneous Commercial ServicesCommercial Services Provide medical courses for continuing professional development | Commercial Services |
Bayer HealthCare Pharmaceuticals, Inc.
 Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drugs | Health Technology |
American Association for The Study of Liver Diseases
American Association for The Study of Liver Diseases Miscellaneous Commercial ServicesCommercial Services Operates as a healthcare organization to prevent and cure liver diseases | Commercial Services |
Université d'Aix-Marseille
 Université d'Aix-Marseille Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rectify Pharmaceuticals LLC
Rectify Pharmaceuticals LLC BiotechnologyHealth Technology Operates as a biotechnology company that develops positive functional modulators | Health Technology |
- Stock Market
- Insiders
- Pol Boudes
